Reliq Health Technologies Inc. (OTCQB: RQHTF)
(TSX-V:RHT) Breaking News -
April 5, 2018
Reliq Health Technologies Announces
Expansion of Paz Home Health Contract by 5,000 New Patients, Increasing Contract
Value to over $9MM USD Annually
VANCOUVER, BC, - April 5, 2018 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company that develops innovative
mobile health (mHealth) and telemedicine solutions for the Community-Based
Healthcare market, is pleased to announce the expansion of its contract with Paz
Home Health LLC in Texas to provide its iUGO Care remote patient monitoring and
telemedicine solution. The revised contract increases the number of Paz Home
Health subscribers by 5,000 patients, bringing the total to over 15,000 patients
total. This will generate over $9 Million USD in annual recurring revenue at
full deployment, by Q4 2018.
“We are excited to announce that as a result of their implementation of the iUGO
Care remote patient monitoring platform, our client Paz Home Health has been
accepted as a Superior HealthPlan Approved Provider for in-home telemonitoring.
Superior HealthPlan is a managed care organization that works with the State of
Texas Health and Human Services
Commission to deliver care through approved providers to Medicare and Medicaid
patients. As a result of becoming an Approved Provider, Paz has increased their
registered Medicare/Medicaid homecare clients to over 15,000 patients across
Southern Texas,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.
“Paz Home Health has successfully demonstrated the benefits of using Reliq’s
iUGO Care remote patient monitoring system to improve health outcomes and reduce
hospital admissions and ER visits in their patients. Reliq’s technology allows
Paz Home Health’s patients to receive high quality care from the comfort of
their own homes, reducing the cost of care delivery and increasing patient and
family satisfaction.”
“Our mission at Paz Home Health is to provide peace of mind for patients and
their loved ones,” said Dayana Bermea, CEO. “We are excited to have achieved
Superior HealthPlan Approved Provider status and look forward to continuing to
grow our patient base in Southern Texas and throughout the State. At Paz Home
Health we are always striving to provide our clients with best in class home
healthcare.”
Paz Home Health LLC is a Superior HealthPlan-approved home care provider
headquartered in Pharr, Texas that provides care to patients across 16 counties
in southern Texas. Paz Home Health delivers in-home care from Registered and
Licensed Vocational Nurses, Physical and Occupational Therapists, Medical Social
Workers and Dieticians. The company also offers telemonitoring services to
connect patients with their care team from the comfort of their own homes. Paz
Home Health’s caring and qualified healthcare providers are committed to
supporting patients and families who are coping with chronic conditions like
Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and
Diabetes, recovering at home from surgery or injuries, and seniors who are aging
in place.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces 12,000
Patients Now Enrolled on its iUGO Care Platform, Hiring of New Sales Team and
Provides Corporate Update
VANCOUVER, BC, - March 29, 2018 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to provide an update on operations to current and future shareholders.
“This has been an extraordinarily busy and productive three months for Reliq
Health,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies. “We’ve been
very internally focused this quarter, working to evolve from a start up to a
mature organization with the necessary infrastructure to support the growth we
anticipate going forward. We have now
successfully built a strong foundation that will allow the Company to ramp up
client acquisition and patient enrollment to address the significant
opportunities in our pipeline. The Company has undertaken major new initiatives
including hiring an experienced Sales team, implementing new CRM and Accounting
systems, moving our code in house, opening a US office and expanding our
Implementation, Technical Leadership, Finance and IR teams. We’ve continued to
execute on our business plan and meet our milestones as forecast, including our
go-live with Sioux Lookout Meno Ya Wen Health Centre in Ontario and ongoing
patient enrollment at our customer sites in Texas, despite the intense effort
required by our internal corporate initiatives. I’d like to thank my entire team
for all of the hard work and long hours they’ve put in over the past three
months, and thank our shareholders for their patience while we completed this
critical work. We’re pleased to share the progress we’ve made this quarter
through the following corporate update.”
Patient Enrollment
The Company has now onboarded over 12,000 patients and is continuing to
add at least 2,000 new patients per month to the platform.
Company Evolution and Expansion
Reliq has undergone significant positive internal change over the last three
months to enable accelerated growth going forward.
This quarter the Company:
- Hired an experienced Sales team consisting of three senior sales staff with a
proven track record of generating more than $200M in sales of healthcare IT
solutions. The Sales team will be in place by mid-April, allowing the Company to
accelerate growth through both the existing pipeline leads and new
opportunities.
- Implemented a new Custom Relationship Management (CRM) system to improve lead
tracking and reduce sales cycles.
- Expanded the Implementation team to support new client deployments.
- Migrated the iUGO Care platform code from a Toronto-based contract development
provider to assume full ownership and control over the Company’s proprietary
source code.
- Built an internal Technical Leadership team to own and manage the Company’s
code and direct all future Development efforts.
- Expanded the Development team substantially while simultaneously reducing
Development costs by engaging a highly respected, experienced contract
development firm in Costa Rica.
- Expanded the Finance team and is in the process of engaging new auditors.
- Hired an Investor Relations resource to start in April to improve shareholder
access to company information. To contact Investor Relations please email
IR@reliqhealth.com.
To streamline the customer acquisition, client onboarding and patient
enrollment processes the Company:
- Opened a US office in McAllen, Texas to provide a base for the Sales team.
- Added practice management and workflow support tools to the platform to
provide clients with a turnkey solution for their organizations.
- Created off-the-shelf training materials for new clients and patients
including videos, online tutorials and printed materials.
- Implemented automated claims submission to Medicare, Medicaid and private
insurers.
Financial Position
On January 9th, 2018 the Company successfully closed an oversubscribed
private placement led by Canaccord Genuity Corp and Gravitas Securities Inc.
with gross proceeds of approximately $10,000,000.
Reliq currently has $13 Million CAD in cash and cash equivalents.
Upcoming Events
2018 ATA Conference
Reliq Health will be exhibiting at the American Telemedicine Association
(ATA) Conference in Chicago, IL April 29 - May 1st, 2018. Come visit us at Booth
#1428!
Reliq Health AGM
The Company will hold its Annual General Meeting (AGM) on May 15th at
10:00am PDT / 1:00pm EDT. Shareholders will receive the AGM materials in mid to
late April.
Company Overview
Reliq Health Technologies is a healthcare technology company that
specializes in developing innovative software solutions for the Community Care
market. Reliq's powerful iUGO Care platform supports care coordination and
community-based healthcare. The iUGO Care platform integrates wearables,
sensors, voice technology and intuitive mobile apps and desktop user interfaces
for patients, clinicians and healthcare administrators. iUGO Care allows complex
patients to receive high quality care at home, improving health outcomes,
enhancing quality of life for patients and families and reducing the cost of
care delivery. Our platform provides real-time access to remote patient
monitoring data, allowing for timely interventions by the care team to prevent
costly hospital readmissions and ER visits. Reliq Health Technologies trades on
the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or IR@reliqhealth.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces Go-Live
of Diabetes Pilot with Sioux Lookout Meno Ya Wen Health Centre
VANCOUVER, BC, - Feb. 27, 2018 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on creating innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has begun onboarding diabetes patients for its
Remote Patient Care pilot with Sioux Lookout Meno Ya Wen Health Centre in Sioux
Lookout, ON. The pilot project is funded by Ontario’s Health Technologies Fund (HTF).
“We are very pleased to partner with Sioux Lookout Meno Ya Wen Health Centre (SLMHC)
to address the healthcare
challenge of poor access to care for diabetes patients living in remote and
rural communities. With the use of our low-touch, high-tech iUGO Care solution,
‘virtual care’ can be provided to diabetes patients in their own communities
throughout Northwestern Ontario,” said Dr. Lisa Crossley, CEO of Reliq Health
Technologies, Inc. “Our platform supports remote patient monitoring and secure
virtual communications, allowing clinicians to identify patients whose condition
is becoming unstable and intervene early, before a serious complication
develops. Sioux Lookout Meno Ya Wen Health Centre provides healthcare to
patients across an area of Northwestern Ontario that is the size of France.
Their commitment to delivering high quality care to patients in even the most
remote communities in this area is inspiring, and we are honoured to be part of
this important initiative.”
Sioux Lookout Meno Ya Wen Health Centre (www.slmhc.on.ca) in Sioux Lookout,
Ontario provides health services to all residents in a large area of
Northwestern Ontario that includes four municipalities and 28 First Nations
communities, including the Nishnawbe-Aski communities north of Sioux Lookout,
the Treaty #3 community of Lac Seul First Nation, Hudson, Pickle Lake and Savant
Lake.
This pilot project is one of 15 that received funding in the first round of
Ontario’s $20-million Health Technology Fund. The fund is administered by
Ontario Centres of Excellence (OCE) on behalf of the Office of the Chief Health
Innovation Strategist (OCHIS), and is a part of the OCHIS mandate to strengthen
Ontario’s health innovation ecosystem. For more information please visit http://www.oce-ontario.org/programs/commercialization-programs/health-technologies-fund.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Named #1 2018 TSX
Venture 50TM Performer, and Reaches 10,000 Patients Live on Its iUGO Care
Platform
VANCOUVER, BC, - Feb. 23, 2018 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) solutions for Community-Based Healthcare, is pleased to
announce it has achieved the #1 ranking in the 2018 TSX Venture 50™ in the
technology sector. The TSX Venture 50™ is the TSX Venture Exchange’s annual
ranking of Canada’s top 50 emerging publicly traded companies.
“We are honoured to have been recognized as the #1 technology stock in the TSX
Venture 50™,” said Dr. Lisa Crossley, CEO of Reliq Health. “I want to thank the
team at Reliq Health for their hard work, dedication and passionate commitment
to building a business aimed at fundamentally disrupting the current model for
healthcare. We also want to thank our shareholders, who have been so supportive
of Reliq’s mission to reduce healthcare costs by improving health outcomes and
access to care.”
The TSX Venture 50 acknowledges the top 10 performing companies listed on the
TSX Venture Exchange in five industry sectors: mining, oil & gas, clean
technology & life sciences, diversified industries, and technology. The winners
are selected based on three equally weighted criteria: market capitalization
growth, share price appreciation and trading volume. The TSXV created a video
profile on Reliq and other 2018 TSX Venture 50™ winners, available at
www.tsx.com/venture50.
Additionally, the company is pleased to announce that it now has 10,000 patients
live on its iUGO Care chronic care management, remote patient monitoring and
telemedicine platform.
Reliq’s iUGO Care digital health solution provides high quality virtual care in
the community by creating a “virtual hospital ward” within the patient’s home,
automatically collecting vital signs and encouraging and tracking medication
adherence. iUGO Care’s unique interactive voice technology provides patients
with audible alerts and reminders to take their medications, collect their
vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab
or fitness activities. iUGO Care’s two-way voice hub provides voice-activated
access to patient education content, empowering patients and family members to
proactively manage complex chronic conditions. Reliq’s iUGO Care cloud platform
instantly alerts the clinical care team if a patient develops key warning signs,
allowing clinicians to intervene before a health crisis occurs, preventing
costly and disruptive hospital readmissions and ER visits.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Issues
Clarification Regarding Announcement of New Client Contract with True Life Home
Health
VANCOUVER, BC, - Jan. 25, 2018 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on creating innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare,
announced earlier today that it has signed an agreement with True Life Home
Health LLC in Texas to provide Reliq’s iUGO Care chronic care management, remote
patient monitoring and telemedicine platform to their over 2,000 home care
clients and that the contract will generate over $1,200,000 USD in gross
recurring annual revenue at full deployment with patient enrolment beginning in
February 2018.
At the request of IIROC, Reliq wishes to disclose that the contracts the Company
has to provide its iUGO Care platform to over 50,000 patients, representing over
$30 Million USD in gross recurring annual revenue at full deployment, have
associated projected gross margins of over 80%.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Announces New
Client Contract with True Life Home Health
VANCOUVER, BC, - Jan. 25, 2018 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on creating innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has signed an agreement with True Life Home Health
LLC in Texas to provide Reliq’s iUGO Care chronic care management, remote
patient monitoring and telemedicine platform to their over 2,000 home care
clients. This contract will generate over $1,200,000 USD in recurring annual
revenue at full deployment. Patient enrolment will begin in February 2018.
In total Reliq now has contracts in place to provide its iUGO Care platform to
over 50,000 patients, representing over $30 Million USD in recurring annual
revenue at full deployment.
“We are very pleased to be working with True Life Home Health to deliver high
quality care to patients in the home,” said Dr. Lisa Crossley, CEO of Reliq
Health Technologies, Inc. “Reliq’s iUGO Care remote patient monitoring system
quickly and easily collects sophisticated health data from patients in their own
homes. Our secure, cloud-based care collaboration
platform provides the clinical care team, patient and family members with
real-time access to patient health information including trends over time. This
helps the care team identify patients whose condition is becoming unstable and
intervene early, before a serious complication develops. Patients and their
loved ones are able to clearly see how compliance with prescribed medication and
lifestyle changes affect the patient’s health status, improving patient
engagement and patient- and family-reported satisfaction. The iUGO Care virtual
care platform was designed to reduce readmissions and improve health outcomes.
Our technology allows patients to receive high quality care from the comfort of
their own homes, reducing the cost of care delivery and increasing patient and
family satisfaction.”
“True Life Home Health is committed to providing high quality care to complex
chronic disease patients in the comfort of their own homes,” said Sonia Anciso,
President. “We are excited to be working with Reliq Health to support our care
providers in their day-to-day workflow, freeing up more time for patient care.
We feel that incorporating cutting edge technologies like the iUGO Care platform
will help True Life improve health outcomes and reduce overall healthcare
costs.”
True Life Home Health is certified by the Centers for Medicare & Medicaid
Services (CMS). The company offers in home care from qualified health
professionals as well as telemonitoring services to connect patients with their
care team from the comfort of their own homes. True Life Home Health’s caring
and qualified healthcare providers are committed to supporting patients and
families who are coping with chronic conditions like Congestive Heart Failure (CHF),
Chronic Obstructive Pulmonary Disease (COPD) and Diabetes, recovering at home
from surgery or injuries, and seniors who are aging in place.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Reaches over
6,000 Patients Live on Its iUGO Care Platform, and Announces that the Company
has Achieved Profitability
VANCOUVER, BC, - Jan. 11, 2018 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) solutions for Community-Based Healthcare, is pleased to
announce that it closed 2017 with over 6,000 paid subscribers using its iUGO
Care chronic care management, remote patient monitoring and telemedicine
platform, representing recurring monthly revenue of over US$300,000/month. As a
result, December 2017 was the Company’s first month of profitability.
“We are excited to announce that we now have over 6,000 patients live on our
iUGO Care platform,” said Dr. Lisa Crossley,
CEO of Reliq Health. “The onboarding of patients is starting to accelerate as we
move forward with our roll out to over 40,000 patients with the three current
contracts in Texas. We are also very pleased to announce that we have achieved
another critical milestone, as the Company reached profitability in December
2017. We continue to focus our efforts on the front line care providers in the
US who are serving the over 37 Million Medicare and Medicaid patients who have
two or more chronic diseases such as diabetes, hypertension, chronic obstructive
pulmonary disease (COPD) and congestive heart failure. This market will continue
to grow as the population ages and expands, and as pressure from lawmakers and
insurers to reduce healthcare spending increases. Our iUGO Care platform allows
healthcare providers to proactively manage complex chronic care patients in the
lower cost community setting, reducing the need for costly acute interventions
such as hospital stays, surgeries, long term care admissions and ER visits.”
Reliq’s iUGO Care digital health solution provides high quality virtual care in
the community by creating a “virtual hospital ward” within the patient’s home,
automatically collecting vital signs and encouraging and tracking medication
adherence. iUGO Care’s unique interactive voice technology provides patients
with audible alerts and reminders to take their medications, collect their
vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab
or fitness activities. iUGO Care’s two-way voice hub provides voice-activated
access to patient education content, empowering patients and family members to
proactively manage complex chronic conditions. Reliq’s iUGO Care cloud platform
instantly alerts the clinical care team if a patient develops key warning signs,
allowing clinicians to intervene before a health crisis occurs, preventing
costly and disruptive hospital readmissions and ER visits.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces Closing
of Oversubscribed $10 Million Brokered Private Placement Co-led by Canaccord
Genuity and Gravitas Securities
VANCOUVER, BC, - Jan. 09, 2018 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce further to its news release dated December 12, 2017, it
successfully closed an oversubscribed private placement (the “Offering”) led by
Canaccord Genuity Corp and Gravitas Securities Inc. (together, the “ Agents”) of
8,928,571 Units (the “Units”) of the Company at a price of $1.12 per Unit
(the “Unit Price”) for gross proceeds of approximately $10,000,000.
Each Unit consists of one (1) common share of the Company (a “Common Share”) and
half of one (1/2) Common Share purchase warrant (each whole Common Share
purchase warrant, a “Warrant”). Each of the 4,464,285 Warrants is exercisable to
acquire one Common Share (a “Warrant Share”) for a period of two years following
the closing date of the Offering at an exercise price of $1.75 per Warrant
Share, subject to adjustment in certain events.
The Company intends to use the net proceeds of the Offering for general working
capital, product development and customer acquisition.
In connection with the Offering, the Company paid the Agents a cash fee of
approximately $800,000 and issued 446,428 Units to the Agents. Additionally, the
Company issued 714,285 compensation warrants to the Agents and another selling
dealer group member (the “Compensation Warrants”), with each Compensation
Warrant entitling the holder to purchase one Unit of the Company at an exercise
price of $1.12 for a period of two years following the closing date of the
Offering. Each warrant issued under the Units is exercisable into one Common
Share of the Company for a period of two years following the closing date of the
Offering at an exercise price of $1.75 per Common Share, subject to adjustment
in certain events.
All securities issued in connection with the Offering are subject to a four
month hold period expiring May 10, 2018.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. does not intend, and does not assume any
obligation, to update these forward-looking statements except as required by
law. These forward-looking statements involve risks and uncertainties relating
to, among other things, technology development and marketing activities, the
Company's historical experience with technology development, uninsured risks.
Actual results may differ materially from those expressed or implied by such
forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces New
Contract with
Texas, USA Based Chronic Care Management Provider Serving 1,000 Complex
Continuing Care Patients
VANCOUVER, BC, - December 20, 2017 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing
innovative mobile health (mHealth) and telemedicine solutions for
Community-Based Healthcare, is pleased to announce that it has signed an
agreement with B Golden Care Services, LLC in McAllen, Texas to implement
Reliq’s iUGO Care chronic care management platform for its 1,000 complex
continuing care patients. Onboarding of patients is expected to begin in late Q1
2018.
“We are excited to be working with B Golden Care Services,” said Dr. Lisa
Crossley, CEO of Reliq Health Technologies, Inc. “Reliq’s iUGO Care platform
will help B Golden track and manage their patients and enable automated claims
submissions to Medicare and Medicaid. iUGO Care helps healthcare organizations
like B Golden provide high quality care more efficiently with tools that support
patient triaging, scheduling, caregiver workflows and billing. Our platform
allows healthcare providers to proactively manage complex chronic care patients
in the lower cost community setting, reducing the need for
costly and disruptive acute interventions such as hospital stays, long term care
admissions and ER visits.”
“Our mandate at B Golden is to support patients with complex chronic conditions
who are aging in place,” said Mr. Joseph Estapa, President and CEO of B Golden
Care Services. “Studies consistently show that providing patients with
medication reminders, coaching and education in the home setting drives patient
engagement and improves health outcomes. We are passionate about improving
access to care for patients in our community and helping people stay healthy and
at home as they age.”
B Golden Care Services, LLC is a new and growing chronic care management agency
in Southern Texas. The company provides services to patients in the home
setting, supporting patients aging in place, improving medication adherence and
empowering patients to proactively manage their own health.
Reliq Health Technologies is a healthcare technology company that specializes in
developing innovative software solutions for the Community Care market. Reliq's
powerful iUGO Care platform supports care coordination and community-based
healthcare. The iUGO Care platform integrates wearables, sensors, voice
technology and intuitive mobile apps and desktop user interfaces for patients,
clinicians and healthcare administrators. iUGO Care allows complex patients to
receive high quality care at home, improving health outcomes, enhancing quality
of life for patients and families and reducing the cost of care delivery.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces
Appointment of Mr. Anthony de Werth to Advisory Board
VANCOUVER, BC, - December 19, 2017 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing
innovative mobile health (mHealth) solutions for Community-Based Healthcare, is
pleased to announce that Mr. Anthony (Tony) de Werth has joined its Advisory
Board.
“We are thrilled to have Mr. de Werth join our Advisory Board,” said Dr. Lisa
Crossley, CEO of Reliq Health. “His Capital Markets expertise and experience
guiding fast-growing companies like hyperWALLET to large scale success will be
invaluable to Reliq Health going forward.”
Mr. de Werth's career in the Canadian Investment Industry spans several decades
and includes progressively senior roles with Merrill Lynch Canada culminating in
the role of Managing Director of the Private Client division before it was
acquired by Wood Gundy. In this role he was responsible for all Merrill Lynch
Canada branches. Upon the successful completion of this acquisition, Mr. de
Werth became the Chairman & CEO of CIBC Wood Gundy Private Client Investments
Inc., in charge of the combined Private Client operation. He was a member of
both the Management Committee and the Executive Committee at CIBC Wood Gundy.
Mr. de Werth has served as a Director/Officer of several public and private
companies including Chairman of hyperWALLET Systems Inc., Chairman of
Rattlesnake Ventures and Director at Minsud Resources Corp. He has also acted in
a legal advisory capacity for several law firms in individual investor matters.
“I’m excited to be part of the Reliq Health team, working towards a common goal
of making healthcare more accessible and affordable,” said Mr. Tony de Werth. “I
look forward to working with this passionate team to make a real contribution to
the future of healthcare.”
Reliq’s iUGO Care digital health solution provides high quality virtual care in
the community by creating a “virtual hospital ward” within the patient’s home,
automatically collecting vital signs and encouraging and tracking medication
adherence. iUGO Care’s unique interactive voice technology provides patients
with audible alerts and reminders to take their medications, collect their
vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab
or fitness activities. iUGO Care’s two-way voice hub provides voice-activated
access to patient education content, empowering patients and family members to
proactively manage complex chronic conditions. Reliq’s iUGO Care cloud platform
instantly alerts the clinical care team if a patient develops key warning signs,
allowing clinicians to intervene before a health crisis occurs, preventing
costly and disruptive hospital readmissions and ER visits.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Announces Lead Subscriber Has
Voluntarily Extended the Hold Period of June 2017 Private Placement to Eight
Months
VANCOUVER, BC, - December 15, 2017 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing
innovative mobile health (mHealth) solutions for Community-Based Healthcare, is
pleased to announce that the lead subscriber from the June 2017 private
placement has agreed to a voluntary extended hold period of eight months. This
extends the hold period to February 22, 2018, from the previous voluntary
extended hold period of six months, which would have had a free trading date of
December 22, 2017. In the June 2017 private placement, 6,937,200 Units (the
“Units”) of the Company were issued at a price of $0.11 per Unit for gross
proceeds of $763,092.00. The lead subscriber purchased 4,545,454 of these Units,
which will now not be free trading until
February 22, 2018.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces
$7,500,000 Brokered Private Placement Co-led by Canaccord Genuity and Gravitas
Securities
VANCOUVER, BC, - December 12, 2017 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has entered into an engagement agreement with
Canaccord Genuity Corp. and Gravitas Securities Inc. to act as co-lead agents on
a commercially reasonable efforts basis in respect to a brokered private
placement offering of up to 6,696,428 units (the "Units") at a price of $1.12
per Unit for gross proceeds of up to $7,500,000 (the "Offering") subject to
completion of satisfactory due diligence. Each Unit will consist of one (1)
common share in the capital of the Company (a "Share") and one-half (1/2)
transferable common share purchase warrant (each whole warrant, a "Warrant"),
with each Warrant exercisable into one additional Share at a price of $1.75 for
a period of two years from the date of closing. The Company intends to use the
net proceeds of the offering for general working capital, product development
and customer acquisition.
The Company has granted the Agents an over-allotment option (the “Over-Allotment
Option”), which may be exercised in the Agents’ sole discretion and without
obligation, exercisable in whole or in part and in one or more tranches at any
time and from time to time prior to the closing of the Offering, to offer up to
an additional 33% of the Units sold under the Offering, with the same terms and
conditions as the Units. This represents up to an additional 2,232,142 Units
under the Offering, which would raise additional gross proceeds of up to
$2,500,000, which would result in a total gross proceeds of up to $10,000,000 to
be raised under the Offering.
“We are pleased to have the continued support of two of Canada’s leading
independent brokerage firms,” said Dr. Lisa Crossley, CEO of Reliq.
The Company may pay a fees and commissions on the Offering within the amount
permitted by the policies of the TSX Venture Exchange (the "Exchange"). Closing
of the Offering is subject to a number of conditions, including receipt of all
necessary corporate and regulatory approvals, including the Exchange. All
securities issued in connection with the Offering will be subject to a statutory
hold period of four months plus a day from the date of issuance in accordance
with applicable securities legislation. The Company anticipates that there may
be insider participation in the Offering.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Reaches over 4,000 Patients
Live on Its iUGO Care Platform, Will Achieve Breakeven in December 2017
VANCOUVER, BC, - November 30, 2017 - Reliq Health
Technologies Inc. (TSX-V:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) solutions for Community-Based Healthcare, is pleased to
announce that it now has over 4,000 paid subscribers using its iUGO Care chronic
care management, remote patient monitoring and telemedicine platform. This
represents recurring monthly revenue of over US$200,000/month; as a result the
Company will reach its breakeven point in December 2017.
“We are excited to announce that we now have over 4,000 patients live on our
iUGO Care platform,” said Dr. Lisa Crossley, CEO of Reliq Health. “The
onboarding of patients is starting to accelerate as we move forward with our
roll out to over 40,000 patients with the two current contracts in Texas. We are
also very pleased to announce that we have achieved another critical milestone,
as the Company will reach breakeven in
December 2017. We continue to focus our efforts on the front line care providers
in the US who are serving the over 37 Million Medicare and Medicaid patients who
have two or more chronic diseases such as diabetes, hypertension, chronic
obstructive pulmonary disease (COPD) and congestive heart failure. This market
will continue to grow as the population ages and expands, and as pressure from
lawmakers and insurers to reduce healthcare spending increases. Our iUGO Care
platform allows healthcare providers to proactively manage complex chronic care
patients in the lower cost community setting, reducing the need for costly acute
interventions such as hospital stays, surgeries, long term care admissions and
ER visits.”
Reliq’s iUGO Care digital health solution provides high quality virtual care in
the community by creating a “virtual hospital ward” within the patient’s home,
automatically collecting vital signs and encouraging and tracking medication
adherence. iUGO Care’s unique interactive voice technology provides patients
with audible alerts and reminders to take their medications, collect their
vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab
or fitness activities. iUGO Care’s two-way voice hub provides voice-activated
access to patient education content, empowering patients and family members to
proactively manage complex chronic conditions. Reliq’s iUGO Care cloud platform
instantly alerts the clinical care team if a patient develops key warning signs,
allowing clinicians to intervene before a health crisis occurs, preventing
costly and disruptive hospital readmissions and ER visits.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Announces Call-In Details for
Quarterly Reporting Call, and Launch of New iUGO Care Website
VANCOUVER, BC, - November 24, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) solutions for Community-Based Healthcare, will host an investor
update conference call to review the Company’s recent progress and answer
questions from shareholders.
Conference Call Information:
When: December 1, 2017, 8:00am – 9:00am PST / 11:00am – noon EST
ID: 3298828
Dial In: Canada and U.S. - (844) 461-9931 International - (636) 812-6630
The Company would like to advise participants to join the conference call at
least 10 minutes early in order to register. Investors are encouraged to submit
questions in advance to info@reliqhealth.com as these questions will be
addressed first, following which the moderator will open up the call to
questions from investors who have registered and joined the queue. To join the
queue participants will be asked to key in *1 at any point in the call. Once the
questions submitted in advance via email have been addressed, the moderator will
open the line to callers in the queue one at a time in order of priority. A
recording of the conference call will be available afterwards until December 8,
2017, and will be accessible by calling either of the following numbers: (855)
869-2056 or (404) 537-3406.
Reliq is also pleased to announce that it has launched a new website for its
iUGO Care product platform at www.iugocare.com. The new website is intended to
support Reliq’s business development and customer outreach efforts and increase
product brand awareness. The site provides detailed information on the iUGO Care
product line, cloud platform, cybersecurity, company partners and customer
testimonials.
Reliq’s iUGO Care digital health solution provides high quality virtual care in
the community by creating a “virtual hospital ward” within the patient’s home,
automatically collecting vital signs and tracking medication adherence. iUGO
Care’s interactive voice technology provides patients with audible alerts and
reminders to take their medications, collect their vitals using
Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness
activities. iUGO Care’s two-way voice hub provides voice-activated access to
patient education content, empowering patients and family members to proactively
manage complex chronic conditions. Reliq’s iUGO Care cloud platform instantly
alerts the clinical care team if a patient develops key warning signs, allowing
clinicians to intervene before a health crisis occurs and preventing costly and
disruptive hospital readmissions and ER visits.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Reaches over
2,000 Patients Live on Its iUGO Care Platform
VANCOUVER, BC, - November 16, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) solutions for Community-Based Healthcare, is pleased to
announce that it now has over 2,000 paid subscribers using its iUGO Care chronic
care management, remote patient monitoring and telemedicine platform,
representing recurring monthly revenue of over US$100,000/month.
“We are excited to announce that we now have over 2,000 patients live on our
iUGO Care platform,” said Dr. Lisa Crossley, CEO of Reliq Health. “The
onboarding of patients is starting to accelerate as we move forward with our
roll out to over 40,000 patients in Texas. We expect to continue to enrol more
than 1,000 new patients per month through 2018 with our
two contracts with Paz Home Health, LLC (Pharr, TX) and Rio Grande Valley Health
Alliance, LLC (McAllen, TX), which together are worth over US$26 Million
annually in recurring revenue at full deployment. We are proud to offer a
solution that comprehensively and cost-effectively addresses the needs of front
line care providers in the community and the more than 37 Million Medicare and
Medicaid patients who have two or more chronic conditions.”
Reliq is also pleased to announce that it has launched a new version of its
corporate website, incorporating improusiness model and provide an
industry-leading resource for information on the Community Healthcare market.
Reliq’s iUGO Care digital health solution provides high quality virtual care in
the community by creating a “virtual hospital ward” within the patient’s home,
automatically collecting vital signs and tracking medication adherence. iUGO
Care’s interactive voice technology provides patients with audible alerts and
reminders to take their medications, collect their vitals using
Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness
activities. iUGO Care’s two-way voice hub provides voice-activated access to
patient education content, empowering patients and family members to proactively
manage complex chronic conditions. Reliq’s iUGO Care cloud platform instantly
alerts the clinical care team if a patient develops key warning signs, allowing
clinicians to intervene before a health crisis occurs and preventing costly and
disruptive hospital readmissions and ER visits.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Announces Receipt of Second
Milestone Payment from NextGen, and Upcoming Investor Call
VANCOUVER, BC, - November 9, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative remote
patient monitoring, care coordination and telemedicine solutions for
Community-Based Healthcare, is pleased to announce that it has received the
second milestone payment from NextGen Applications LLC of San Antonio, TX (“NextGen”
- NextGenApplicationsLLC.com, info@nextgenapplicationsllc.com) per the contract
between Reliq and NextGen. The contract, whose total value is $1.22 Million USD,
provides NextGen with professional services and a limited license to Reliq’s
proprietary iUGO Care platform, specifically for the development of a consumer
focused mobile health app (“mTelecare App”), providing service to the greater
San Antonio area before expanding elsewhere throughout the U.S.
“We are pleased to have achieved the second milestone in this contract on
schedule,” said Dr. Lisa Crossley, CEO of Reliq Health. “NextGen’s initiative to
improve health outcomes and enhance access to care through the mTelecare App is
directly aligned with Reliq’s focus on Community-Based Healthcare. Working in
conjunction with NextGen Applications, we will be able to leverage our existing
platform to create a customized mobile health app that will allow the residents
of San Antonio and elsewhere to proactively manage their own health.”
“NextGen’s partnership with Reliq Health will allow us to utilize their existing
mHealth platform to provide a novel, innovative mobile healthcare solution to
the citizens of San Antonio and surrounding area,” said a spokesperson of
NextGen Applications. “The resulting mTelecare mobile app will provide a
telemedicine platform that connects patients to doctors and nurses anywhere
where there is internet access. mTelecare will support secure video consults for
patients with doctors and nurses, providing patients with professional care from
the comfort of their own home. The mTelecare app will also provide automated
prescription refills, search tools for healthcare services, a personalized
health calendar with push notifications, reminders and a suite of billing and
payment tools. mTelecare will provide greater access to healthcare, while at the
same time reducing healthcare costs.”
The City of San Antonio, Texas is the seventh most populated city in the United
States and the second most populated city in Texas, with a population of over
1.4 Million residents.
The Company is also pleased to announce that it will be hosting a investor call
on December 1, 2017 at 8:00am PST/11:00am EST. Please visit the Company’s
website (www.reliqhealth.com) the week of November 20, 2017 for call in details
and information on how to submit your questions electronically in advance of the
call.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. does not intend, and does not assume any
obligation, to update these forward-looking statements except as required by
law. These forward-looking statements involve risks and uncertainties relating
to, among other things, technology development and marketing activities, the
Company's historical experience with technology development, uninsured risks.
Actual results may differ materially from those expressed or implied by such
forward-looking statements.
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
SOURCE: Reliq Health Technologies Inc.
____________________
Recent RQHTF News:
Reliq Health Technologies Announces Closing
of Oversubscribed $5 Million Brokered Private Placement
VANCOUVER, BC, - November 2, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce further to its news releases dated October 11 and 30, 2017,
it successfully closed an oversubscribed private placement (the “Offering”) led
by Canaccord Genuity Corp and Gravitas Securities Inc. (together, the “Co-Lead
Agents”) and Beacon Securities Limited (“Beacon” and together with the Co-Lead
Agents, the “Agents”) of 12,500,000 Units (the “Units”) of the Company at a
price of $0.40 per Unit (the “Unit Price”) for gross proceeds of $5,000,000.
Each Unit consists of one (1) common share of the Company (a “Common Share”) and
half of one (1/2) Common Share purchase warrant (each whole Common Share
purchase warrant, a “Warrant”). Each of the 6,250,000 Warrants is exercisable to
acquire one Common Share (a “Warrant Share”) for a period of two years following
the closing date of the Offering at an exercise price of $0.60 per Warrant
Share,
subject to adjustment in certain events.
“We are very pleased to have completed a successful oversubscribed financing and
to have three of Canada’s leading independent rokerage firms support the
Company,” said Dr. Lisa Crossley, CEO of Reliq.
The Company intends to use the net proceeds of the Offering for general working
capital, product development and customer acquisition.
In connection with the Offering, the Company paid the Agents a cash fee of
$340,000 and issued 625,000 Units to the Agents. Additionally, the Company
issued 850,000 compensation warrants to the Agents and other selling dealer
group members (the “Compensation Warrants”), with each Compensation Warrant
entitling the holder to purchase one Unit of the Company at an exercise price of
$0.40 for a period of two years following the closing date of the Offering. Each
warrant issued under the Units is exercisable into one Common Share of the
Company for a period of two years following the exercise of the Compensation
Warrant at an exercise price of $0.60 per Common Share, subject to adjustment in
certain events.
All securities issued in connection with the Offering are subject to a four
month hold period expiring March 3, 2018.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information Certain statements
in this press release constitute forward-looking statements, within the meaning
of applicable securities laws. All statements that are not historical facts,
including without limitation, statements regarding future estimates, plans,
programs, forecasts, projections, objectives, assumptions, expectations or
beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. does not intend, and does not assume any
obligation, to update these forward-looking statements except as required by
law. These forward-looking statements involve risks and uncertainties relating
to, among other things, technology development and marketing activities, the
Company's historical experience with technology development, uninsured risks.
Actual results may differ materially from those expressed or implied by such
forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Corrects Offering
Size of Brokered Private Placement and Announces Exercise of Over-Allotment
Option
VANCOUVER, BC, - October 24, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare,
wishes to clarify its news release on October 17, 2017. The Company intends to
offer a private placement financing of up 10,000,000 units of the Company (the
“Units”) at a price of $0.40 per Unit for gross proceeds of $4,000,000 (the
“Offering”). The Offering is led by Canaccord Genuity Corp. and Gravitas
Securities Inc. (collectively, the “Agents”).
Each Unit will consist of one (1) common share of the Company (a “Common Share”)
and half of one (1/2) Common Share purchase warrant (each whole Common Share
purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one
Common Share (a “Warrant Share”) for a period of two years following the closing
date of the Offering at an exercise price of $0.60 per Warrant Share, subject to
adjustment in certain events.
The Company has granted the Agents an over-allotment option (the “Over-Allotment
Option”), which may be exercised in the Agents’ sole discretion and without
obligation, exercisable in whole or in part and in one or more tranches at any
time and from time to time prior to the closing of the Offering, to offer up to
an additional 25% of the Units sold under the Offering, with the same terms and
conditions as the Units. The Agents have elected to exercise the Over-Allotment
Option in full to offer an additional 2,500,000 Units under the Offering. This
will raise additional gross proceeds of $1,000,000, resulting in a total gross
proceeds of up to $5,000,000 to be raised under the Offering.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. does not intend, and does not assume any
obligation, to update these forward-looking statements except as required by
law. These forward-looking statements involve risks and uncertainties relating
to, among other things, technology development and marketing activities, the
Company's historical experience with technology development, uninsured risks.
Actual results may differ materially from those expressed or implied by such
forward-looking statements.
Source: Reliq Health Technologies Inc.
Reliq Health Technologies CEO, Dr. Lisa
Crossley, to Present at StableView TECH17
VANCOUVER, BC, - October 24, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that the Company’s CEO Dr. Lisa Crossley will be presenting
at the StableView Asset Management TECH17 Conference in Toronto, ON on Thursday,
October 26, 2017 at 10:45am.
“We are excited to be a part of StableView’s annual conference and look forward
to sharing our progress and business plan for growth with attendees,” said Reliq
Health CEO, Dr. Lisa Crossley.
About StableView TECH17
StableView Asset Management hosts StableView TECH17. The 4th annual StableView
TECH17 showcases the most innovative ideas, themes and challenges in Technology
today. As the only buy-side curated tech conference in Canada, StableView TECH17
sits at the junction of the public and private investing tech ecosystem in
Canada and brings together participants that typically stay in their individual
silos: institutional investors, pensions, VCs, broker-dealers, advisors, HNW
investors and family offices with private and public tech companies in Canada.
On October 26th, 2017, approximately 25 of Canada's leading technology companies
will be presenting to an expected audience of over 450+ professionals
representing approximately $350B in AUM.
About Reliq Health Technologies
Reliq Health Technologies is a healthcare technology company that specializes in
developing innovative software solutions for the Community Care market. Reliq's
powerful iUGO Care platform supports care coordination and community-based
healthcare. The iUGO Care platform integrates wearables, sensors, voice
technology and intuitive mobile apps and desktop user interfaces for patients,
clinicians and healthcare administrators. iUGO Care allows complex patients to
receive high quality care at home, improving health outcomes, enhancing quality
of life for patients and families and reducing the cost of care delivery. Our
platform provides real-time access to remote patient monitoring data, allowing
for timely interventions by the care team to prevent costly hospital
readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture
under the symbol RHT and on the OTCQB as RQHTF.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Announces Upsize
of Previously Announced Private Placement Financing to $5.0 Million
VANCOUVER, BC, - October 17, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that due to high demand it has amended the terms of its
previously announced private placement financing to increase the size of the
offering from $4,000,000 to $5,000,000 (the "Upsized Offering").
Under the terms of the Upsized Offering Canaccord Genuity Corp. and Gravitas
Securities Inc. have been engaged to act as co-lead agents on a commercially
reasonable efforts basis in respect to a brokered private placement offering of
up to 12,500,000 units (the "Units") at a price of $0.40 per Unit for gross
proceeds of up to $5,000,000 (the "Offering") subject to completion of
satisfactory due diligence. Each Unit will consist of one (1) common share in
the capital of the Company (a
"Share") and one-half (1/2) transferable common share purchase warrant (each
whole warrant, a "Warrant"), with each Warrant exercisable into one additional
Share at a price of $0.60 for a period of two years from the date of closing.
The Company intends to use the net proceeds of the offering for general working
capital, product development and customer acquisition.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. does not intend, and does not assume any
obligation, to update these forward-looking statements except as required by
law. These forward-looking statements involve risks and uncertainties relating
to, among other things, technology development and marketing activities, the
Company's historical experience with technology development, uninsured risks.
Actual results may differ materially from those expressed or implied by such
forward-looking statements.
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Announces
$4,000,000 Brokered Private Placement Co-led by Canaccord Genuity and Gravitas
Securities
VANCOUVER, BC, - October 11, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has entered into an engagement agreement with
Canaccord Genuity Corp. and Gravitas Securities Inc. to act as co-lead agents on
a commercially reasonable efforts basis in respect to a brokered private
placement offering of up to 10,000,000 units (the "Units") at a price of $0.40
per Unit for gross proceeds of up to $4,000,000 (the "Offering") subject to
completion of satisfactory due diligence. Each Unit will consist of one (1)
common share in the capital of the Company (a "Share") and one-half (1/2)
transferable common share purchase warrant (each whole warrant, a "Warrant"),
with each Warrant exercisable into one additional Share at a price of $0.60 for
a period of two years from the date of closing. The Company intends to use the
net proceeds of the offering for general working capital, product development
and customer acquisition.
“We are delighted to have two of Canada’s leading independent brokerage firms
support the Company,” said Dr. Lisa
Crossley, CEO of Reliq.
The Company may pay fees and commissions on the Offering within the amount
permitted by the policies of the TSX Venture Exchange (the "Exchange"). Closing
of the Offering is subject to a number of conditions, including receipt of all
necessary corporate and regulatory approvals, including the Exchange. All
securities issued in connection with the Offering will be subject to a statutory
hold period of four months plus a day from the date of issuance in accordance
with applicable securities legislation.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
About Canaccord Genuity Group Inc.:
Through its principal subsidiaries, Canaccord Genuity Group Inc. ("Canaccord")
is a leading independent, full-service financial services firm, with operations
in two principal segments of the securities industry: wealth management and
capital markets. Since its establishment in 1950, Canaccord has been driven by
an unwavering commitment to building lasting client relationships. We achieve
this by generating value for our individual, institutional and corporate clients
through comprehensive investment solutions, brokerage services and investment
banking services. Canaccord has offices in 10 countries worldwide, including
Wealth Management offices located in Canada, the UK, Guernsey, Jersey, the Isle
of Man and Australia. Canaccord Genuity, the international capital markets
division, operates in Canada, the US, the UK, France, Ireland, Hong Kong, China,
Australia and Dubai. To us there are no foreign markets.™
Canaccord Genuity Group Inc. is publicly traded under the symbol CF on the TSX.
About Gravitas Securities Inc.:
Gravitas is known for sophisticated sector expertise, tactical individuals with
a commitment to excellence, global integration and innovation, and as a leading
independent wealth management and capital markets firm. Gravitas provides a wide
range of investment mandates and services for retail and corporate clients
globally from offices in Toronto, Vancouver and Calgary, and is represented in
the United States through its FINRA (Financial Industry Regulatory Authority)
representative, Gravitas Capital International, in New York and San Francisco.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. does not intend, and does not assume any
obligation, to update these forward-looking statements except as required by
law. These forward-looking statements involve risks and uncertainties relating
to, among other things, technology development and marketing activities, the
Company's historical experience with technology development, uninsured risks.
Actual results may differ materially from those expressed or implied by such
forward-looking statements.
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Reaches First
Major Milestone of 1,000 Patients Live on Its Remote Patient Monitoring and
Telemedicine Platform
VANCOUVER, BC, - October 5, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it now has 1,000 paid subscribers using its chronic
care management, remote patient monitoring and telemedicine solution,
representing recurring monthly revenue of US$50,000/month.
“We are excited to announce that we now have 1,000 patients live on our
platform,” said Dr. Lisa Crossley, CEO of Reliq Health. “This is a critical
milestone for Reliq as we move forward with our roll out to over 40,000 patients
in accordance with our previously-announced contracts with Paz Home Health, LLC
(Pharr, TX) and Rio Grande Valley Health Alliance, LLC (McAllen, TX). We expect
to enroll at least 1,000 new patients per month through 2018 with these two
contracts, which together are worth over US$26 Million annually in recurring
revenue at full deployment.”
Reliq’s digital health solution provides high quality virtual care in the
community by creating a “virtual hospital ward” within the patient’s home,
automatically collecting vital signs and tracking medication adherence. Reliq’s
interactive voice technology provides patients with audible alerts and reminders
to take their medications, collect their vitals using
Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness
activities. Reliq’s two-way voice hub provides voice-activated access to patient
education content, empowering patients and family members to proactively manage
complex chronic conditions. The Reliq Health cloud platform instantly alerts the
clinical care team if a patient develops key warning signs, allowing clinicians
to intervene before a health crisis occurs and preventing costly and disruptive
hospital readmissions and ER visits.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information Certain statements
in this press release constitute forward-looking statements, within the meaning
of applicable securities laws. All statements that are not historical facts,
including without limitation, statements regarding future estimates, plans,
programs, forecasts, projections, objectives, assumptions, expectations or
beliefs of future performance, are "forward-looking statements". We caution you
that such "forward-looking statements" involve known and unknown risks and
uncertainties that could cause actual and future events to differ materially
from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces
Subscribers Have Voluntarily Extended Hold Period of June 2017 Private Placement
VANCOUVER, BC, - Sept. 28, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing
innovative mobile health (mHealth) and telemedicine solutions for
Community-Based Healthcare, would like provide clarification on the news
released issued, June 22nd, 2017, in regards to the private placement at a price
of $0.11 per Unit (the “Units”) for a gross proceeds of $736,092.00. All of the
subscribers of the said financing have agreed to a voluntary extended hold
period of 6 months, to December 22, 2017, from its previous 4 month hold period
which would have had a free trading date of October 22, 2017.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
Source: Reliq Health Technologies Inc.
Reliq Health Announces Receipt of $200,000
USD Payment from NextGen Applications LLC, San Antonio, TX
VANCOUVER, BC, - Sept. 19, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has received the first payment of US$200,000 from
NextGen Applications LLC of San Antonio, TX (the “NextGen” -
NextGenApplicationsLLC.com - info@nextgenapplicationsllc.com) per the
contract between Reliq and NextGen. The contract, whose total value is $1.22
Million USD, provides NextGen with professional services and a limited license
to Reliq’s proprietary iUGO Health platform, specifically for the development of
a consumer focused mobile health app (the “mTelecare App”), providing service to
the greater San Antonio area before expanding elsewhere throughout the U.S.
“We are excited to be part of NextGen’s initiative to improve health outcomes
and enhance access to care,” said Dr. Lisa Crossley, CEO of Reliq Health. “Our
virtual care platform uses a high tech, low touch approach to provide high
quality healthcare in the home while reducing the cost of care delivery. Working
in conjunction with NextGen Applications, we will be able to leverage our
existing platform to create a customized mobile health app that will allow the
residents of San
Antonio and elsewhere to proactively manage their own health.”
“NextGen’s partnership with Reliq Health will allow us to utilize their existing
mHealth platform to provide a novel, innovative mobile healthcare solution to
the citizens of San Antonio and surrounding area,” said a spokesperson of
NextGen Applications. “The resulting mTelecare mobile app will provide a
telemedicine platform that connects patients to doctors and nurses anywhere
where there is internet access. mTelecare will support secure video consults for
patients with doctors and nurses, providing patients with professional care from
the comfort of their own home. The mTelecare app will also provide automated
prescription refills, search tools for healthcare services, a personalized
health calendar with push notifications, reminders and a suite of billing and
payment tools. mTelecare will provide greater access to healthcare, while at the
same time reducing healthcare costs.”
The City of San Antonio, Texas is the seventh most populated city in the United
States and the second most populated city in Texas, with a population of over
1.4 Million residents.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information Certain statements
in this press release constitute forward-looking statements, within the meaning
of applicable securities laws. All statements that are not historical facts,
including without limitation, statements regarding future estimates, plans,
programs, forecasts, projections, objectives, assumptions, expectations or
beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
SOURCE: Reliq Health Technologies Inc.
Reliq Health Announces Appointment of Dr.
Richard Sztramko as Chief Medical Officer
VANCOUVER, BC, - Sept. 14, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that Dr. Richard Sztramko has joined the company as its
Chief Medical Officer, working out of the Company’s operational headquarters in
Hamilton, Ontario.
“We are thrilled to have a physician with Dr. Sztramko’s experience and clinical
expertise join our team,” said Dr. Lisa Crossley, CEO of Reliq Health. “His
background in Geriatrics and General Internal Medicine and his entrepreneurial
experience in the eHealth space will make him an invaluable resource for the
Company and for our customers. As we roll out our platform to >48,000 patients
at Paz Home Health (Pharr, TX) and the Rio Grande Valley Health Alliance Accountable
Care Organization (McAllen, TX) and bring on new customers in the future, Dr.
Sztramko’s clinical background will help us ensure that our products
comprehensively support clinicians’ workflows while delivering best in class
virtual healthcare to their patients.”
“I’m very excited about working with the rest of the Reliq Health team to
provide innovative, user-friendly virtual care and telemedicine solutions to
patients in the community,” said Dr. Sztramko. “Studies consistently show that
providing patients with the tools they need for self-management of their chronic
conditions produces better health outcomes and reduces healthcare costs. Reliq’s
remote patient monitoring system quickly and easily collects sophisticated
health data from patients in their own homes. The secure, cloud-based care
collaboration platform provides the clinical care team, patient and family
members with real-time access to patient health information including trends
over time. This helps clinicians like myself identify high risk patients and
intervene early, before a serious complication develops, improving health
outcomes, preventing readmissions and ER visits, reducing healthcare costs and
increasing patient and family satisfaction.”
Dr. Sztramko practices Geriatric and General Internal Medicine at St. Peter’s,
Hamilton General, and Juravinski Hospitals in Hamilton, Ontario, Canada. Prior
to joining Reliq Health he co-founded Virtual Ward, a startup focused on
healthcare provider communication within hospitals, and created an online
education tool for patients with Dementia and their caregivers (iGeriCare).
Reliq’s digital health solution provides high quality virtual care in the
community by creating a “virtual hospital ward” within the patient’s home,
automatically collecting vital signs and tracking medication adherence. Reliq’s
interactive voice technology provides patients with audible alerts and reminders
to take their medications, collect their vitals using Bluetooth-enabled
“wearables” and perform prescribed rehab or fitness activities. Reliq’s two-way
voice hub provides voice-activated access to patient education content,
empowering patients and family members to proactively manage complex chronic
conditions. The Reliq Health cloud platform instantly alerts the clinical care
team if a patient develops key warning signs, allowing clinicians to intervene
before a health crisis occurs and preventing costly and disruptive hospital
readmissions and ER visits.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Announces Go-Live
with Paz Home Health, USA - >$6MMUSD in Annual Recurring Revenue at Full
Deployment
VANCOUVER, BC, - Aug. 17, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce the go-live of remote patient monitoring, care coordination
and telemedicine platform with their Rio Grande Valley Health Alliance, LLC (RGVHA)
in McAllen, Texas. The Company has begun enrolling the first of RGVHA’s >30,000
Primary Care patients. The Company expects to add >500 patients to the
platform each month going forward, generating over $20 Million USD in recurring
annual revenue at full deployment.
“We are excited to be working with Rio Grande Valley Health Alliance (RGVHA) to
support care coordination across multiple clinical settings, improving health
outcomes and reducing the cost of care delivery for their patients,” said Dr.
Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Reliq’s remote patient
monitoring system quickly and easily collects comprehensive health data from
patients in their own homes. Our secure, cloud-based care collaboration platform
provides the clinical care
team, patient and family members with real-time access to patient health
information including trends over time. This helps the care team identify
patients whose condition is becoming unstable and intervene early, before a
serious complication develops requiring an ER visit or hospital admission. The
care coordination portal allows patients and their loved ones to clearly see how
compliance with prescribed medication and lifestyle changes affect the patient’s
health, improving patient engagement and patient- and family-reported
satisfaction.”
“Our mission at Rio Grande Valley Health Alliance is to provide better, more
efficient care for our patients as an Accountable Care Organization,” said Dr.
Luis Delgado, Jr., President. “We are excited to be working with Reliq Health to
ensure that our patients receive the best possible care, and that we as their
physicians are alerted immediately when patients need additional attention. This
is critical to reducing hospital readmissions, ensuring patients successfully
transition home after a hospital stay, and preventing medication confusion for
complex patients. Reliq’s telemedicine platform will allow us to provide
patients who are not able to travel to appointments with secure video consults
in the comfort of their own homes, improving access to care for patients in
remote and rural communities.”
Rio Grande Valley Health Alliance, LLC (www.rgvha.org) is an Accountable Care
Organization (ACO). The group is comprised of 17 primary care physicians who are
working with Medicare to provide better coordinated care to Medicare
Fee-for-Service patients. The aim of the ACO is to deliver high-quality care and
lower growth in health care expenditures. The ACO is made up of 15 independent
practices focusing on primary care, and currently has over 30,000 registered
patients.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces Go-Live
with Paz Home Health, USA - >$6MMUSD in Annual Recurring Revenue at Full
Deployment
VANCOUVER, BC, - Aug. 01, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company that develops innovative mobile health (mHealth)
and telemedicine solutions for the Community-Based Healthcare market, is pleased
to announce the go-live of its remote patient monitoring and telemedicine
solution with Paz Home Health LLC in Texas. The Company has begun enrolling the
first of Paz’s >10,000 patients. The Company expects to add >500 Paz Home Health
patients to the platform each month going forward, generating over $6 Million in
recurring annual revenue at full deployment.
“We are excited to be implementing our virtual care platform in Texas with Paz
Home Health,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.
“Reliq’s remote patient monitoring system quickly and easily collects
sophisticated health data from patients in their own homes. Our virtual care
platform was designed to reduce readmissions and improve health
outcomes. Reliq’s technology allows Paz Home Health’s patients to receive high
quality care from the comfort of their own homes, reducing the cost of care
delivery and increasing patient and family satisfaction.”
“Our mission at Paz Home Health is to provide peace of mind for patients and
their loved ones,” said Dayana Bermea, CEO. “We are excited to be working with
Reliq Health to support our care providers in their day-to-day workflow, freeing
up more time for patient care. Reliq Health’s cloud-based portal will allow our
clients’ family members to access real-time information about their loved one’s
health status, care team and home visit schedule. Patients and their families
can feel secure knowing that the Reliq Health system will continuously monitor
the patient at home and summon emergency services if needed. At Paz Home Health
we are always striving to provide our clients with best in class home
healthcare.”
Paz Home Health LLC is a home care agency headquartered in Pharr, Texas that
provides care to over 10,000 patients across 16 counties in southern Texas. Paz
Home Health delivers in-home care from Registered and Licensed Vocational
Nurses, Physical and Occupational Therapists, Medical Social Workers and
Dieticians. The company also offers telemonitoring services to connect patients
with their care team from the comfort of their own homes. Paz Home Health’s
caring and qualified healthcare providers are committed to supporting patients
and families who are coping with chronic conditions like Congestive Heart
Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes,
recovering at home from surgery or injuries, and seniors who are aging in place.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
Source: Reliq Health Technologies Inc.
Reliq Health Provides Corporate Update
VANCOUVER, BC, -06/23/17 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announced that further to its news release dated June 9, 2017 and
June 22, 2017, the Company has received final TSX Venture Exchange approval on
the non-brokered private placement of 6,937,200 Units (the "Units") of the
Company at a price of $0.11 per Unit for gross proceeds of $763,092.00.
Each Unit each consists of one (1) common share (the "Common Share") and one
half (1/2) transferrable share purchase warrant (the "Warrant"). Each of the
3,468,600 warrants entitles the holder thereof to purchase one (1) additional
Common Share.
The subscribers to the private placement agreed to a voluntary 6 month hold
period on securities issued.
Total Pro Group involvement for 4,546,200 Units in the amount of $500,000.00 was
subscribed for by one individual.
ON BEHALF OF THE BOARD
Dr. Lisa Crossley, CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com
Source: Reliq Health Technologies Inc.
Reliq Health Announces Closing of
Oversubscribed Non-Brokered Private Placement with Gravitas Securities as
Exclusive Financial Advisors
VANCOUVER, BC, - 06/22/17 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announced that further to its news release dated June 9, 2017, it
successfully closed an oversubscribed non-brokered private placement of
6,937,200 Units (the "Units") of the Company at a price of $0.11 per Unit for
gross proceeds of $763,092.00.
Each Unit each consists of one (1) common share (the "Common Share") and one
half (1/2) transferrable share purchase warrant (the "Warrant"). Each of the
3,468,600 warrants entitles the holder thereof to purchase one (1) additional
Common Share on or before June 21, 2019 at a price of CDN$0.165 per Common
Share.
"We're very pleased to complete a successful oversubscribed offering," said Dr.
Lisa Crossley, CEO of Reliq. "Gravitas played an instrumental role in the
success of the private placement as exclusive advisor."
In accordance with the policies of the TSX Venture Exchange, the Company paid
Finders' Fees of an aggregate of $61,047.36 in cash and an aggregate of 554,976
finder warrants (the "Finder Warrant"). Each Finder Warrant will entitle the
holder thereof to purchase one (1) additional Common Share on or before June 21,
2019 at a price of CDN$0.165 per Common Share.
The securities issued are subject to a 4 month hold period that expires on
October 22, 2017.
About Gravitas Securities Inc.
Gravitas is known for sophisticated sector expertise, tactical individuals with
a commitment to excellence, global integration and innovation, and as a leading
independent wealth management and capital markets firm. Gravitas provides a wide
range of investment mandates and services for retail and corporate clients
globally from offices in Toronto, Vancouver, and Calgary, and is represented in
the United States through its FINRA representative, Gravitas Capital
International, in New York and San Francisco.
ON BEHALF OF THE BOARD
Dr. Lisa Crossley, CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Corporate Update
VANCOUVER, BC, - April 21, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that further to the Company's news releases dated March 29,
2017 and April 20, 2017 the Company has received TSX Venture Exchange (the
"Exchange") final approval and closed the convertible debenture financing (the
"Financing") for gross proceeds of $762,304.97.
All or any portion of the principal amount under the Loans are convertible by
the Lenders into units (the "Units") of the
Company at any time before the maturity date at a conversion price per Unit of
$0.13. Each Unit consists of one (1) common share in the capital of the Company
(a "Common Share") and one-half (1/2) share purchase warrant (a "Warrant"). Each
full Warrant entitles the holder to purchase one additional Common Share in the
capital of the Company (a "Warrant Share") at a price of $0.20 per Warrant Share
for a period of thirty-six (36) months from the date of conversion.
The funds received will be used by the Company for ongoing corporate and general
working capital purposes.
Subscribers of the Financing have agreed to a voluntary hold period of 6 months.
In accordance with the policies of the TSX Venture Exchange, the Company paid a
Finders' Fee of an aggregate of $15,280.00 and 350,000 finders warrants. Each
Finder's Warrant entitles the Finder to acquire one common share at a price of
$0.20 for a period of 12 months, expiring on April 21, 2018.
As a subscriber to the Financing, Aman Thindal, a Director and Officer of the
Issuer may acquire directly or indirectly 769,230 Units upon conversion of the
convertible debenture. The participation by an insider in the Financing is
considered to be a "related party transaction" as defined under Multilateral
Instrument 61-101 ("MI 61-101"). The transaction is exempt from the formal
valuation and minority shareholder approval requirements of MI 61-101, as
neither the fair market value of the securities being issued nor the
consideration being paid exceeds 25% of the Company's market capitalization.
Company Overview
Reliq Health Technologies is a healthcare technology company that specializes in
developing innovative software solutions for the Community Care market. Reliq's
powerful iUGO Care platform supports care coordination and community-based
healthcare. The iUGO Care platform integrates wearables, sensors, voice
technology and intuitive mobile apps and desktop user interfaces for patients,
clinicians and healthcare administrators. iUGO Care allows complex patients to
receive high quality care at home, improving health outcomes, enhancing quality
of life for patients and families and reducing the cost of care delivery. Our
platform provides real-time access to remote patient monitoring data, allowing
for timely interventions by the care team to prevent costly hospital
readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture
under the symbol RHT and on the OTCQB as RQHTF.
ON BEHALF OF THE BOARD
Dr. Lisa Crossley, CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Renmark Financial Communications Inc.
Laura Welsh
lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Announces Paid
Pilot with Rio Grande Valley Health Alliance (McAllen, Texas), Primary Care
Provider to over 30,000 Patients
VANCOUVER, BC, - Apr 6, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has signed an agreement with Rio Grande Valley
Health Alliance, LLC in McAllen, Texas to pilot Reliq's remote patient
monitoring, care coordination and telemedicine platform with their primary care
patients. The pilot will go live in May, 2017.
"We are excited to be working with Rio Grande Valley Health Alliance (RGVHA) to
support care coordination across multiple clinical settings, improving health
outcomes and reducing the cost of care delivery for their patients," said Dr.
Lisa Crossley, CEO of Reliq Health Technologies, Inc. "Reliq's remote patient
monitoring system quickly and easily collects comprehensive health data from
patients in their own homes. Our secure, cloud-based care collaboration platform
provides the clinical care team, patient and family members with real-time
access to patient health information including trends over time. This helps the
care team identify patients whose condition is becoming unstable and intervene
early, before a serious complication develops requiring an ER visit or hospital
admission. The care coordination portal allows patients and their loved ones to
clearly see how compliance with prescribed medication and lifestyle changes
affect the patient's health, improving patient engagement and patient- and
family-reported satisfaction."
"Our mission at Rio Grande Valley Health Alliance is to provide better, more
efficient care for our patients as an Accountable
Care Organization," said Dr. Luis Delgado, Jr., President. "We are excited to be
working with Reliq Health to ensure that our patients receive the best possible
care, and that we as their physicians are alerted immediately when patients need
additional attention. This is critical to reducing hospital readmissions,
ensuring patients successfully transition home after a hospital stay, and
preventing medication confusion for complex patients. Reliq's telemedicine
platform will allow us to provide patients who are not able to travel to
appointments with secure video appointments in the comfort of their own homes,
improving access to care for patients in remote and rural communities."
Rio Grande Valley Health Alliance, LLC (www.rgvha.org) is an Accountable Care
Organization (ACO). The group is comprised of 17 primary care physicians who are
working with Medicare to provide better coordinated care to Medicare
Fee-for-Service patients. The aim of the ACO is to deliver high-quality care and
lower growth in health care expenditures. The ACO is made up of 15 independent
practices focusing on primary care, and currently has over 30,000 registered
patients.
ON BEHALF OF THE BOARD
Dr. Lisa Crossley, CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Renmark Financial Communications Inc.
Laura Welsh
(416) 644-2020 or (514) 939-3989
lwelsh@renmarkfinancial.com
www.renmarkfinancial.com
CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Corporate Update
VANCOUVER, BC, - Mar 29, 2017 - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to provide the following corporate update to current and future
shareholders surrounding the recent developments at the Company.
Contracts and Pilot Programs
Reliq has launched a portfolio of remote patient monitoring, care collaboration
and telemedicine solutions and has secured the following contracts and pilots:
Reliq has secured a contract with the Paz Home Health in McAllen, Texas that is
expected to generate over US$6 million in recurring annual revenue by 2018.
Under the terms of the contract, Reliq will provide its remote patient
monitoring and care collaboration platform to Paz's homecare providers and
10,000+ patients. The first 500 patients are expected to go live on the platform
in June 2017 ramping up to the full 10,000+ patient population by the end of Q1
2018, corresponding to recurring revenue of over US$500,000/month.
Reliq has also secured a contract with the City of San Antonio, Texas to provide
a white-labelled version of Reliq's platform to proactively support the health
and wellness of the City's 1.4 million residents. The majority of the revenue
from this contract is expected to be received between Q2 and Q4 2017.
The Company is currently piloting its software with the National Health Service
(NHS) England at Imperial College Hospital, London, UK. The NHS is the largest
single payer healthcare system worldwide, providing coverage for over 54 million
UK
residents. The pilot will end in Q3 2017.
Reliq has an ongoing pilot with Florida-based Sacred Heart Health System (a
five-hospital regional healthcare network). Sacred Heart admits more than 30,000
patients annually and is a part of Ascension Health - the largest Catholic,
non-profit health care system in the US and one of the largest global healthcare
networks. The pilot will conclude in late Q2 2017.
The Company also has an ongoing pilot with The Feldman Institute in Baton Rouge,
LA, an interventional pain management clinic that performs thousands of pain
management surgeries annually. The pilot is expected to conclude in April 2017.
Reliq will be launching a pilot with Hamilton Health Sciences (HHS) in Hamilton,
ON in April 2017. HHS is a five-hospital network that treats over 50,000
patients and performs over 28,000 surgeries each year.
Cannabis Business Initiatives
Recently, Reliq signed a Memorandum of Understanding (MoU) with Invictus MD
Strategies Corp. (IMH.CN) (IVITF) to provide Poda (an Invictus portfolio
company) with an app its customers can use to track and manage their medical
marijuana usage.
Reliq is building a secure clinical database designed to systematically
anonymize, aggregate and analyze data collected from medical marijuana patients
using Reliq's patient apps. The anonymized clinical data will be used to
statistically correlate variables such as dosage, strain and mode of
administration with symptom relief and side effects. Ultimately this efficacy
and safety data can be used to help identify the optimal strain and dosage for a
given patient's specific clinical condition.
Upcoming milestones in the next 6-12 months:
Reliq is focused on continuing to secure new contracts with home care agencies,
assisted living facilities and hospitals in the United States and Canada
The Company expects to achieve profitability by the end of 2017
Cash Position
The Company has received $164,416 from the exercise of warrants as of March 28,
2017. Additionally, due to investor interest the Company intends to close a
convertible debenture of up to $700,000, subject to the TSX Venture Exchange
approval. The Company's CFO will subscribe to $100,000 of this debenture.
Subscribers of the debenture have agreed to a voluntary hold period of 6 months.
Company Overview
Reliq Health Technologies is a healthcare technology company that specializes in
developing innovative software solutions for the Community Care market. Reliq's
powerful iUGO Care platform supports care coordination and community-based
healthcare. The iUGO Care platform integrates wearables, sensors, voice
technology and intuitive mobile apps and desktop user interfaces for patients,
clinicians and healthcare administrators. iUGO Care allows complex patients to
receive high quality care at home, improving health outcomes, enhancing quality
of life for patients and families and reducing the cost of care delivery. Our
platform provides real-time access to remote patient monitoring data, allowing
for timely interventions by the care team to prevent costly hospital
readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture
under the symbol RHT and on the OTCQB as RQHTF.
ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Renmark Financial Communications Inc.
Laura Welsh
lwelsh@renmarkfinancial.com
(416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Signs Agreement
with Paz Home Health, TX, USA to Provide Remote Patient Monitoring to >10,000
Home Care Clients
VANCOUVER, BC, - February 16, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on creating innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has signed an agreement with Paz Home Health LLC in
Texas to provide Reliq’s hardware and software solutions to their home care
clients. Patient enrollment will begin in March 2017 with 500 Paz Home Health
patients, building to over 10,000 patients and over $6 Million in recurring
annual revenue in 2018.
“We are very pleased to be working with Paz Home Health to deliver high quality
care to patients in the home,” said Dr. Lisa Crossley, CEO of Reliq Health
Technologies, Inc. “Reliq’s remote patient monitoring system quickly and easily
collects sophisticated health data from patients in their own homes. Our secure,
cloud-based care collaboration platform provides the clinical care team, patient
and family members with real-time
access to patient health information including trends over time. This helps the
care team identify patients whose condition is becoming unstable and intervene
early, before a serious complication develops. Patients and their loved ones are
able to clearly see how compliance with prescribed medication and lifestyle
changes affect the patient’s health measures, improving patient engagement and
patient- and family-reported satisfaction. Reliq’s virtual care platform was
designed to reduce readmissions and improve health outcomes. Our technology
allows patients to receive high quality care from the comfort of their own
homes, reducing the cost of care delivery and increasing patient and family
satisfaction.”
“Our mission at Paz Home Health is to provide peace of mind for patients and
their loved ones,” said Dayana Bermea, CEO. “We are excited to be working with
Reliq Health to support our care providers in their day-to-day workflow, freeing
up more time for patient care. Reliq Health’s cloud-based portal will allow our
clients’ family members to access real-time information about their loved one’s
health status, care team and home visit schedule. Patients and their families
can feel secure knowing that the Reliq Health system will continuously monitor
the patient at home and summon emergency services if needed. At Paz Home Health
we are always striving to provide our clients with best in class home
healthcare.”
Paz Home Health LLC is a home care agency headquartered in Pharr, Texas that
provides care to over 10,000 patients across 16 counties in southern Texas. Paz
Home Health delivers in-home care from Registered and Licensed Vocational
Nurses, Physical and Occupational Therapists, Medical Social Workers and
Dieticians. The company also offers telemonitoring services to connect patients
with their care team from the comfort of their own homes. Paz Home Health’s
caring and qualified healthcare providers are committed to supporting patients
and families who are coping with chronic conditions like Congestive Heart
Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes,
recovering at home from surgery or injuries, and seniors who are aging in place.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies and Invictus MD
Strategies Corp. Sign MOU to Collaborate on App for Cannabis Prescribers,
Patients and Consumers
VANCOUVER, BC, - February 7, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), is pleased to announce that it has entered into a Memorandum
of Understanding (MOU) with Invictus MD Strategies Corp. (CSE: IMH; OTC:
IVITF; FRA: 8IS) (“Invictus MD”) to develop a mobile application for
cannabis patients and consumers and their clinical care teams.
Reliq Health, a healthcare technology company focused on developing innovative
mobile health and telemedicine solutions, has developed a novel SaaS (software
as a service) solution for the community health care market. The solution
provides automated remote patient monitoring in the home and secure cloud-based
communication, care planning and collaboration for all members of the patient’s
circle of care. Reliq’s secure platform allows clinicians to collect
comprehensive data on patients’ clinical conditions, medication usage, symptoms,
side effects and behaviours – creating a wealth of population health data.
“Studies consistently show that providing patients with the tools they need for
self-management of their health conditions produces better health outcomes and
reduces healthcare costs. Cannabis is prescribed to treat a wide range of
conditions including arthritis, glaucoma, side effects from chemotherapy,
chronic pain, multiple sclerosis and post-traumatic stress
disorder. Our cannabis app allows patients to track usage and record symptoms
specific to their clinical condition, allowing patients and their care providers
to determine optimum strain, dosing and mode of administration. Our platform
will improve access to care by connecting patients with physicians in their
community who have experience with medical marijuana, and supports
physician-approved automated prescription refills through participating
producers,” said Dr. Lisa Crossley, CEO of Reliq.
Invictus MD’s Chairman and CEO, Dan Kriznic, said, “Our wholly owned subsidiary:
Poda Technologies Ltd. (“Poda”) is set for a launch in Q2 2017 of its Poda Pod
vaporizer product which will provide an effective, reliable and convenient way
to vaporize cannabis that is designed to appeal to modern retail and medical
consumers.” The Poda Pod vaporizer product, made with medical-grade components,
has been designed to connect to users’ smartphones via Bluetooth to provide real
time information about dosage, product characteristics, track remaining
contents, find vendors nearby, and customize their experience. Agreements are
being negotiated to license the PODA products to the Access to Cannabis for
Medical Purposes Regulations (“ACMPR”) and licensed producers in Canada, helping
those producers better reach and serve consumers with convenient, refillable
devices.
Mr. Kriznic added, “Invictus MD is excited and committed to working
collaboratively with Reliq on this innovative mobile application to explore how
Reliq’s solution can support Invictus’ commitment to its patients and consumers
of cannabis products. Reliq’s technology platform will give Invictus the ability
to collect relevant anonymized consumer data such as usage trends, frequency of
usage and other relevant insights to improve the overall experience for medical
marijuana patients.”
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces
Development of Mobile App for Cannabis Patients
VANCOUVER, BC, - January 19, 2017 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has developed a novel mobile application to support
patients who have been prescribed medical marijuana.
"As part of our commitment to high quality patient care in the home, Reliq
Health is proud to be launching a mobile application that will help medical
marijuana consumers track their usage and record their symptoms," said Dr. Lisa
Crossley, CEO of Reliq Health. "Studies consistently show that providing
patients with the tools they need for self-management of their health conditions
produces better health outcomes and reduces healthcare costs. Cannabis is
prescribed to treat a
wide range of conditions including arthritis, glaucoma, side effects from
chemotherapy, chronic pain, multiple sclerosis and post-traumatic stress
disorder. Our app allows patients to track cannabis usage and record symptoms
specific to their clinical condition, allowing patients and their care providers
to determine optimum strain, dosing and mode of administration. Our platform
improves access to care by connecting patients with physicians in their
community who have experience with medical marijuana, and supports
physician-approved automated prescription refills through participating
producers."
Reliq intends to market the app to medical cannabis companies in Canada and
other jurisdictions where cannabis can be legally prescribed.
ON BEHALF OF THE BOARD
Dr. Lisa Crossley, CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Opens Office in
London, UK to Support Pilot at Imperial College Hospital and Further Expansion
into the European Market
VANCOUVER, BC, - December 8, 2016 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has opened an office in the UK to support Reliq's
expansion into the European market.
"We are very pleased to be opening an office in London, England in response to
strong interest from the UK market," said Dr. Lisa Crossley, CEO of Reliq Health
Technologies, Inc. "Reliq recently launched a pilot with the NHS England at
Imperial College Hospital in London to validate the use of our remote patient
monitoring and care collaboration solution for patients
with chronic conditions. Opening an office in the UK allows us to better support
this pilot and acquire new customers in the UK and the rest of Europe. Reliq's
virtual care platform was designed to reduce readmissions and improve health
outcomes for patients with chronic conditions like Congestive Heart Failure (CHF),
Chronic Obstructive Pulmonary Disease (COPD) and Diabetes. Our technology allows
patients to receive high quality care from the comfort of their own homes,
reducing the cost of care delivery and increasing patient and family
satisfaction."
Currently there are over 15 million people in England living with at least one
long-term health condition. In addition to the impact on people's lives,
long-term condition management accounts for half of all General Practitioner
appointments and 70% of hospital bed days in the UK. Reliq Health's proprietary
hardware and software supports patients and their caregivers in the home,
providing remote vitals monitoring with alerts to clinicians as needed, audible
reminders to improve patient compliance with prescribed medication regimens and
lifestyle changes, tailored patient education and secure communication with the
entire care team.
Reliq's UK office is located at Impact Hub Westminster, 1st Floor New Zealand
House, 80 Haymarket, London SW1Y 4TE. The entire funding for the UK office was
provided by the UK Department of International Trade's Global Entrepreneur
Programme, which supports entrepreneurs and early stage technology businesses
that wish to locate in the UK.
ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE Reliq Health Technologies Inc.
Reliq Health Technologies Announces Patient
Enrollment at The Feldman Institute in Louisiana for Pilot to Improve Access to
Care for Interventional Pain Management Patients Post-Surgery
VANCOUVER, BC, - December 1, 2016 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing
innovative mobile health (mHealth) and telemedicine solutions for
Community-Based Healthcare, is pleased to announce that it has begun enrolling
patients for the pilot of its remote patient monitoring and secure communication
solution with The Feldman Institute in Baton Rouge, Louisiana. The pilot will
evaluate the use of Reliq Health’s technology with patients who have been
discharged home after interventional pain management surgery, or have returned
to their homes between treatments at The Feldman Institute.
“We are very pleased to be enrolling patients and launching our pilot of the
Reliq Health platform with The Feldman Institute,” said Dr. Lisa Crossley, CEO
of Reliq Health Technologies, Inc. “Our virtual care solution allows patients to
receive
high quality follow up care from the comfort of their own homes. Patients can
communicate with their care team at The Feldman Institute using Reliq’s
cloud-based secure messaging, videoconferencing and virtual visits. The Reliq
Health cloud provides access to patient education materials and instructional
videos, empowering patients and their families to actively participate in their
own care at home. We look forward to working with The Feldman Institute to
improve treatment outcomes, reduce the risk of post-surgical complications and
increase access to specialized pain management care for their chronic pain
patients.”
“One of our key goals at The Feldman Institute is to provide our patients
with compassionate, accessible healthcare.” said Dr. Arnold E. Feldman, Medical
Director at The Feldman Institute and First Choice Surgery Center. “Our pilot
with Reliq Health is designed to validate the use of their virtual care solution
to help our patients better manage and document their symptoms in the home, and
facilitate secure and timely communication between patients and family members
and their care team at The Feldman Institute. Many of our patients travel great
distances to receive cutting edge pain management surgery and other treatments
at our facility. With Reliq Health’s remote patient monitoring and secure
communication platform we can continue to provide high quality care to these
patients even after they return home.”
The Feldman Institute's mission is to relieve chronic pain and restore
health, comfort and quality of life in a collaborative and compassionate
environment. The Feldman Institute is committed to eliminating pain through
research and innovation while working closely with each patient to find their
appropriate level of care. The Feldman Institute is dedicated to helping its
patients through a comprehensive program of interventional pain management. The
Feldman Institute specializes in performing minimally invasive, outpatient, and
Endoscopic Discectomy procedures to address problems such as herniated discs,
bulging discs, or ruptured discs. These advanced procedures are alternatives to
open back and neck surgery and do not require general anesthesia. Patients
undergoing these procedures experience far less trauma and a much shorter
recovery time. The diagnosis and treatment techniques offered at the Feldman
Institute represent the leading edge of recent medical advances.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces Patient
Enrollment at Sacred Heart Health System in Florida for Pilot to Reduce
Readmissions and Improve Health Outcomes for Congestive Heart Failure Patients
VANCOUVER, BC, - November 10, 2016 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has begun enrolling patients for the pilot of its
remote patient monitoring and care collaboration solution with Sacred Heart
Health System in Florida.
The pilot is specifically aimed at reducing readmissions for Sacred Heart's
Congestive Heart Failure (the "CHF") patients. CHF affects over 6 Million
Americans, and over 21% of all patients in the US who are admitted to hospital
for CHF will be readmitted within 30 days of discharge. All-cause 30-day
readmissions cost the US healthcare system over $41 Billion annually.
Reliq's digital health solution reduces readmissions by creating a "virtual
hospital ward" within the patient's home, automatically collecting vital signs
and tracking medication adherence. Reliq's interactive voice technology provides
patients with audible alerts and reminders to take their medications, collect
their vitals using Bluetooth-enabled "wearables" and perform prescribed rehab or
fitness activities. Reliq's two-way voice hub provides voice-activated access to
patient
education content, empowering patients and family members to proactively manage
complex chronic conditions. The Reliq Health cloud platform instantly alerts the
clinical care team if a patient develops key warning signs, allowing clinicians
to intervene before a health crisis occurs and preventing costly and disruptive
hospital readmissions and ER visits.
"We are very excited to be enrolling patients and launching our pilot with
Sacred Heart Health System in Florida," said Dr. Lisa Crossley, CEO of Reliq
Health. "Studies consistently show that providing patients with the tools they
need for self-management of their chronic conditions produces better health
outcomes and reduces healthcare costs. Reliq's remote patient monitoring system
quickly and easily collects sophisticated health data from patients in their own
homes. Our secure, cloud-based care collaboration platform provides the clinical
care team, patient and family members with real-time access to patient health
information including trends over time. This helps the care team identify high
risk patients and intervene early, before a serious complication develops.
Patients and their loved ones are able to clearly see how compliance with
prescribed medication and lifestyle changes affect the patient's health
measures, improving patient engagement and patient- and family-reported
satisfaction."
Sacred Heart Health System is Northwest Florida's leading provider of
high-quality health care to children and adults. The hub of the Sacred Heart
system is its 566-bed Sacred Heart Hospital in Pensacola. The facilities in
Pensacola include The Children's Hospital at Sacred Heart, a Level II Trauma
Center, a Cancer Center affiliated with MD Anderson Cancer Network, the area's
only program specializing in maternal-fetal medicine, and a cardiovascular
program ranked as one of the top 50 in the nation by Truven Analytics. The
Health System also includes Sacred Heart Hospital on the Emerald Coast, a 58-bed
community hospital near Destin, Sacred Heart Hospital on the Gulf, a 19-bed
hospital, in Port St. Joe, and Sacred Heart Medical Group, a large regional
network of primary care and specialty physicians with offices across seven
coastal counties between Gulf Shores, Ala. and Apalachicola, FL. Sacred Heart is
part of Ascension Health, the nation's largest system of Catholic and non-profit
health care facilities.
ON BEHALF OF THE BOARD
Dr. Lisa Crossley, CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
CORE Capital Partners
604-566-9233
investors@ccpartnersinc.com
Source: Reliq Health Technologies Inc.
Reliq Health Technologies Announces Patient
Enrollment at Imperial College Hospital London for Pilot with National Health
Service England for Remote Patient Monitoring and Care Collaboration
VANCOUVER, BC, - November 10, 2016 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has begun enrolling patients in the pilot of its
remote patient monitoring and care collaboration solution with the NHS England.
“We are very excited to be launching our pilot with the NHS England and
enrolling patients at our pilot site, Imperial College Hospital, London, UK.”
said Dr. Lisa Crossley, CEO of Reliq Health. “The goal of this pilot is to
demonstrate the value of Reliq Health’s self-care solution in improving health
outcomes and reducing the cost of care delivery for chronic disease patients
after they are discharged home from hospital. Our platform uses a combination of
secure cloud-based software, voice technology, wearables and sensors to support
patients and their loved ones in proactively managing their chronic conditions
at home, reducing exacerbations and disease-related complications, decreasing
healthcare costs and enhancing patient and family satisfaction”.
The NHS England is the largest single-payer healthcare system in the world, with
an annual budget of over £100 Billion. There are over 15 million patients in
England who are coping with at least one long-term health condition. These
chronic conditions not only negatively impact patients’ quality of life, but
also account for over half of all General Practitioner (GP) appointments and 70%
of hospital bed days. NHS England has estimated that improvements in self-care
in this population could result in £584m in savings by 2021. Reliq’s digital
health solution creates a fully automated “virtual hospital ward” in the
patient’s home, providing real-time tracking of patients’ vital signs,
medication adherence, and movements within the home. The Reliq Health platform
provides patients with audible alerts and reminders to collect their vitals,
take their medications and perform prescribed rehab or fitness activities to
support proactive self-care. Patient education materials are also provided
through the Reliq Health platform to help patients and their families better
understand and manage their chronic conditions.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies Announces Pilot
with Hamilton Health Sciences and McMaster University to Pilot Its Remote
Patient Monitoring and Care Collaboration Solution
VANCOUVER, BC, - November 3, 2016 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has signed an agreement with Hamilton Health
Sciences and McMaster University in Hamilton, ON to pilot its remote patient
monitoring and care collaboration solution. The pilot is expected to commence in
February 2017.
"We are very excited to work with Hamilton Health Sciences (the "HHS") and
McMaster University to improve health outcomes for patients with Peripheral
Arterial Disease (the "PAD"). Our collaboration with McMaster and HHS will allow
us to deliver a digital health solution for self-care and patient education that
is uniquely tailored to the needs of PAD outpatients." said Dr. Lisa Crossley,
CEO of Reliq Health. "Our platform uses a high tech, low touch approach to
provide high quality healthcare in the home, reducing exacerbations and
disease-related complications, decreasing healthcare costs and enhancing patient
and family satisfaction".
Peripheral Arterial Disease affects over 800,000 Canadians and over 8 Million
Americans. PAD can cause pain, fatigue, poor circulation and slow wound healing
in the extremities. Unless properly managed, PAD can lead to significant
complications including infection, gangrene and amputations. Reliq Health's
proprietary hardware and software supports patients and their caregivers in the
home, providing remote monitoring with alerts to clinicians as needed, audible
reminders to improve patient compliance with prescribed medication regimens and
lifestyle changes, tailored digital patient education materials and secure
communication with the entire care team. Studies have consistently shown that
providing patients and families with the tools they need to better understand
and manage their clinical conditions at home leads to better health outcomes.
ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
SOURCE Reliq Health Technologies Inc.
Reliq Health Announces Community Care Pilot
with the United Kingdom (UK) National Health Service
VANCOUVER, BC, - AUGUST 02, 2016 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce that it has been accepted into the National Health Service (NHS)
United Kingdom’s (UK’s) Test Beds program and will begin piloting its virtual
care technology with a London-area hospital in Q4 2016.
“We are very excited to be piloting Reliq’s community care platform in the UK.
Our technology is strongly aligned with the NHS England’s ongoing initiative to
improve the management of long term conditions in the community.” said Dr. Lisa
Crossley, CEO of Reliq Health. “Our platform uses a high tech, low touch
approach to provide high quality healthcare in the home, reducing exacerbations
and disease-related complications, decreasing healthcare costs and enhancing
patient and family satisfaction. We look forward to participating in the NHS
Test Beds program to demonstrate the value of Reliq Health’s technology to
patients, caregivers and the health system in the UK”.
The pilot will focus on two of the most common chronic conditions in the UK,
congestive heart failure (CHF) and diabetes. Currently there are over 15 million
people in England living with at least one long-term health condition. In
addition to the impact on people’s lives, long-term condition management
accounts for half of all General Practitioner appointments and 70% of hospital
bed days in the UK. Reliq Health’s proprietary hardware and software supports
patients and their caregivers in the home, providing remote vitals monitoring
with alerts to clinicians as needed, audible reminders to improve patient
compliance with prescribed medication regimens and lifestyle changes, tailored
patient education and secure communication with the entire care team.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
Reliq Health Technologies Inc.
#1128 – 789 West Pender Street
Vancouver, B.C., V6C 1H2
Phone: 778-707-6673
Fax: 604-608-3906
SOURCE: Reliq Health Technologies Inc.
Brian Storseth Joins Reliq Health
Technologies’ Board of Directors
VANCOUVER, BC, - JULY 28, 2016 / - Reliq Health
Technologies Inc. (TSXV:RHT
OTCQB:RQHTF) (“Reliq”
or the “Company”), a technology company focused on developing innovative mobile
health (mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to announce Mr. Brian Storseth has joined the Company’s Board of
Directors effective immediately.
Mr. Storseth is a businessman and was a Member of Parliament (MP) with the
Conservative Party of Canada for 9 years from 2006 to 2015 – he did not seek
re-election in 2016. During his tenure as an MP he served on committees for
Aboriginal affairs, agriculture and agri-food.
“Brian is an accomplished business leader and policy expert, having spent 9
years as an MP in the House of Commons. Brian is intimately familiar with issues
relevant to Canadian companies such as ours. We are excited to leverage his
network and experience in order to further expand Reliq’s footprint in Canada,”
said Dr. Lisa Crossley, CEO of Reliq Health.
“I admire how far Reliq has come in a very short period of time and am impressed
with the traction the team has achieved with their technology in the United
States. I look forward to working with them to introduce the technology to
various Provinces, health authorities and other potential users. Using
technology like Reliq’s to improve efficiencies, reduce costs and improve the
quality of care is the future of healthcare for both publicly and privately
funded systems,” said Mr. Brian Storseth.
Mr. Storseth will be granted 250,000 options at $0.15 upon approval from the TSX
Venture Exchange.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information: CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements,
within the meaning of applicable securities laws. All statements that are not
historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions,
expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown
risks and uncertainties that could cause actual and future events to differ
materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with
respect to commercial operations, including technology development, anticipated
revenues, projected size of market, and other information that is based on
forecasts of future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not
assume any obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology development and
marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those
expressed or implied by such forward-looking statements.
Reliq Health Technologies Inc.
#1128 – 789 West Pender Street
Vancouver, B.C., V6C 1H2
Phone: 778-707-6673
Fax: 604-608-3906
SOURCE: Reliq Health Technologies Inc.
---------------------------------------
About Reliq Health Technologies:
Reliq Health Technologies is a Vancouver, BC based healthcare technology company
that specializes in developing innovative, secure mobile software solutions for
the $20 Billion Community Care market. Reliq’s iUGO Health technology platform
is a comprehensive hardware and software solution that allows complex patients
to receive high quality care in the home, improving health outcomes, enhancing
quality of life for patients & families and reducing the cost of care delivery.
iUGO Health
iUGO Health is a wholly-owned subsidiary of Reliq Health Technologies
iUGO Health has built a powerful platform for care coordination and home
healthcare that integrates wearables, sensors, voice technology and intuitive
mobile apps and desktop user interfaces for patients, families, clinicians and
healthcare administrators. iUGO Health allows complex patients to receive high
quality care at home, improving health outcomes, enhancing quality of life for
patients and families and reducing the cost of care delivery. Our platform
provides real-time access to remote patient monitoring data, allowing for timely
interventions by the care team to prevent costly hospital readmissions and ER
visits.
Leadership Team
Our leadership team has a strong track record of building successful companies
in healthcare and technology.
Dr. Lisa Crossley, PhD., P.Eng.
CEO
Dr. Crossley is an accomplished healthcare technology executive with a proven
track record of successfully building and leading global tech companies. She has
diverse experience across multiple market segments, including healthcare
information technology, therapeutics, medical devices, life science tools and
diagnostics. Most recently, Dr. Crossley was CEO of VitalHub Corp., a healthcare
IT company that provides clinicians with secure mobile access to comprehensive
patient health information. Her prior experience includes leadership positions
as CEO of Quantum Dental Technologies and President & CEO of Natrix Separations.
Dr. Crossley has raised over $35 Million in venture capital and angel financing,
negotiated channel partner agreements with major multinational market leaders
and built customer bases in North America, Europe and Asia. She holds a B.Sc. in
Anatomy & Cell Biology from McGill University and a B.A.Sc. and Ph.D. in
Chemical
Engineering from Queen’s University, and is a licensed Professional Engineer in
the Province of Ontario. Dr. Crossley currently serves on the Genome Alberta
Board of Directors and on the Mitacs Research Council. She has previously acted
as a Board Director for the Ontario Bioscience Innovation Organization (OBIO),
Viron Therapeutics, Boyd Technologies, and Women in Science and Technology
Businesses (WSTB) and has held numerous Advisory Board appointments. She was a
member of the Council of Canadian Academies’ Expert Panel commissioned by
Industry Canada to conduct a comprehensive assessment of the State of Industrial
R&D in Canada.
Giancarlo De Lio
CVO
An experienced entrepreneur, Giancarlo has previously founded numerous
successful businesses in the marketing, digital, healthcare and IT markets
including his most recent success, VitalHub Corp., which developed a mobile
charting application for the enterprise mHealth market. Prior to VitalHub
Giancarlo worked at Mount Sinai Hospital in Toronto, developing innovative IT
solutions for the clinical teams. Giancarlo holds a B.Sc. in Computer Science
from the University of Toronto and an MBA from the University of Toronto’s
Rotman School of Management.
Aman Thindal
CFO & Director
Aman Thindal is the Chief Financial Officer at Moseda Technologies Inc. He has
over 6 years of experience and knowledge as an independent investor and has
provided consulting services to private companies. Prior to Joining Moseda
Technologies Inc., Mr. Thindal spent 4 years as a partner and CFO of a Greater
Vancouver based private mid-tier real estate development company where he played
an active role in land acquisitions, financial management, human resources and
marketing of the company’s projects. During his tenure Mr. Thindal helped the
company secure over $75,000,000 in both traditional mortgage and private equity
financing. Mr. Thindal obtained his Chartered Accountant Designation in 2010 and
he holds a Bachelor of Business Administration degree with joint concentration
in Accounting and Finance from Simon Fraser University.
Leo Godreault
VP of Products
Leo is a Registered Nurse and a serial entrepreneur with a strong background in
Information Technology. Leo has previously founded SmartMED, a healthcare IT
company designed to improve the patient and clinician experience. Leo brings a
unique combination of IT expertise and clinical experience to the CareKit Health
team. Leo holds a BScN from McMaster University and Mohawk College..
SOURCE: www.reliqhealth.com
Disclaimer
FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM)
which is a third party publisher that disseminates electronic information
through multiple online media channels. FNMG's intended purposes are to deliver
market updates and news alerts issued from private and publicly trading
companies as well as providing coverage and increased awareness for companies
that issue press to the public via online newswires. FNMG and its affiliated
companies are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's
market updates, news alerts and corporate profiles are NOT a solicitation or
recommendation to buy, sell or hold securities. The material in this release is
intended to be strictly informational and is NEVER to be construed or
interpreted as research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed financial
professional before considering any level of investing in stocks. The companies
that are discussed in this release may or may not have approved the statements
made in this release. Information in this release is derived from a variety of
sources that may or may not include the referenced company's publicly
disseminated information. The accuracy or completeness of the information is not
warranted and is only as reliable as the sources from which it was obtained.
While this information is believed to be reliable, such reliability cannot be
guaranteed. FNMG disclaims any and all liability as to the completeness or
accuracy of the information contained and any omissions of material fact in this
release. This release may contain technical inaccuracies or typographical
errors. It is strongly recommended that any purchase or sale decision be
discussed with a financial adviser, or a broker-dealer, or a member of any
financial regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high degree of
risk. FNMG is not liable for any investment decisions by its readers or
subscribers. Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. This release is not without bias, and
is considered a conflict of interest if compensation has been received by FNMG
for its dissemination. To comply with Section 17(b) of the Securities Act of
1933, FNMG shall always disclose any compensation it has received, or expects to
receive in the future, for the dissemination of the information found herein on
behalf of one or more of the companies mentioned in this release. For current
services performed FNMG has been compensated three thousand nine hundred
dollars for Reliq Health Technologies Inc. news coverage by a non-affiliated third party.
FNMG HOLDS NO SHARES OF Reliq Health Technologies Inc.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and FNMG undertakes no obligation to update such
statements.
|
